VOLUME 68   2007   NUMBER 6

 

Original Articles

818 Adherence to Atypical Antipsychotic Treatment Among Newly Treated Patients: A Population-Based Study in Schizophrenia. Dan Cooper, Jocelyne Moisan, and Jean-Pierre Grégoire
[Abstract] [PDF]

826 Augmentation of Antidepressants With Atypical Antipsychotic Medications for Treatment-Resistant Major Depressive Disorder: A Meta-Analysis. George I. Papakostas, Richard C. Shelton, Juliana Smith, and Maurizio Fava
[Abstract] [PDF]

832 Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Acute Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study. René S. Kahn, S. Charles Schulz, Veselin D. Palazov, Efren B. Reyes, Martin Brecher, Ola Svensson, Henrik M. Andersson, and Didier Meulien, on behalf of the Study 132 Investigators
[Abstract] [PDF]

843 The Efficacy and Safety of Aripiprazole as Adjunctive Therapy in Major Depressive Disorder: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study. Robert M. Berman, Ronald N. Marcus, René Swanink, Robert D. McQuade, William H. Carson, Patricia K. Corey-Lisle, and Arif Khan
[Abstract] [PDF]

854 Psychoeducation in Schizophrenia: 7-Year Follow-Up Concerning Rehospitalization and Days in Hospital in the Munich Psychosis Information Project Study. Josef Bäuml, Gabriele Pitschel-Walz, Anja Volz, Rolf R. Engel, and Werner Kissling
[Abstract] [PDF]

862 The Influence of Media Coverage of a Celebrity Suicide on Subsequent Suicide Attempts. Andrew T. A. Cheng, Keith Hawton, Tony H. H. Chen, Amy M. F. Yen, Chung-Ying Chen, Lin-Chen Chen, and Po-Ren Teng
[Abstract] [PDF]

867 Provider and Patient Characteristics Associated With Antidepressant Nonadherence: The Impact of Provider Specialty. Kara Zivin Bambauer, Stephen B. Soumerai, Alyce S. Adams, Fang Zhang, and Dennis Ross-Degnan
[Abstract] [PDF]

874 Alcohol Use Disorders and Panic Disorder: A Review of the Evidence of a Direct Relationship. Fiammetta Cosci, Koen R. J. Schruers, Kenneth Abrams, and Eric J. L. Griez
[Abstract] [PDF]

881 Lack of Efficacy of 5 Grams Daily of Creatine in Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Trial. Alex Kaptsan, Alex Odessky, Yamima Osher, and Joseph Levine
[Abstract] [PDF]

885 Do Comorbid Personality Disorders Moderate Panic-Focused Psychotherapy? An Exploratory Examination of the American Psychiatric Association Practice Guideline. Barbara L. Milrod, Andrew C. Leon, Jacques P. Barber, John C. Markowitz, and Elizabeth Graf
[Abstract] [PDF]

892 Short-Term Naturalistic Treatment Outcomes in Cigarette Smokers With Substance Abuse and/or Mental Illness. [CME] Risa B. Gershon Grand, Sun Hwang, Juliette Han, Tony George, and Arthur L. Brody
[Abstract] [PDF]

899 Increased Mortality Among Patients Admitted With Major Psychiatric Disorders: A Register-Based Study Comparing Mortality in Unipolar Depressive Disorder, Bipolar Affective Disorder, Schizoaffective Disorder, and Schizophrenia. Thomas Munk Laursen, Trine Munk-Olsen, Merete Nordentoft, and Preben Bo Mortensen
[Abstract] [PDF]

908 Association of Suicide and Antidepressant Prescription Rates in Japan, 1999-2003. Atsuo Nakagawa, Michael F. Grunebaum, Steven P. Ellis, Maria A. Oquendo, Haruo Kashima, Robert D. Gibbons, and J. John Mann
[Abstract] [PDF]

917 The Level of Cardiovascular Risk Factors in Bipolar Disorder Equals That of Schizophrenia: A Comparative Study. Astrid B. Birkenaes, Stein Opjordsmoen, Cathrine Brunborg, John A. Engh, Halldora Jonsdottir, P. Andreas Ringen, Carmen Simonsen, Anja Vaskinn, Kĺre I. Birkeland, Svein Friis, Kjetil Sundet, and Ole A. Andreassen
[Abstract] [PDF]

924 Using Interpreters in Diagnostic Research and Practice: Pilot Results and Recommendations. Luis H. Zayas, Leopoldo J. Cabassa, M. Carmela Perez, and Patricia A. Cavazos-Rehg
[Abstract] [PDF]

929 Conventional or Atypical Antipsychotics and the Risk of Femur Fracture Among Elderly Patients: Results of a Case-Control Study. Rosa Liperoti, Graziano Onder, Kate L. Lapane, Vincent Mor, Joseph H. Friedman, Roberto Bernabei, and Giovanni Gambassi
[Abstract] [PDF]

935 Acceleration and Augmentation of Antidepressants With Lithium for Depressive Disorders: Two Meta-Analyses of Randomized, Placebo-Controlled Trials. Nicolas Andres Crossley and Michael Bauer
[Abstract] [PDF]

Focus on Women's Mental Health

941 Sex Hormones and the Female Brain: The Toll of Variability and Deficiency. Marlene P. Freeman
[PDF]

943 Treatment of Depression and Menopause-Related Symptoms With the Serotonin-Norepinephrine Reuptake Inhibitor Duloxetine. Hadine Joffe, Claudio N. Soares, Laura F. Petrillo, Adele C. Viguera, Brittny L. Somley, Jennifer K. Koch, and Lee S. Cohen
[Abstract] [PDF]

951 Acute Worsening of Chronic Depression During a Double-Blind, Randomized Clinical Trial of Antidepressant Efficacy: Differences by Sex and Menopausal Status. Anne T. Harvey, Beryl S. Silkey, Susan G. Kornstein, and Cathryn M. Clary
[Abstract] [PDF]

959 Androgen Deficiency: Association With Increased Anxiety and Depression Symptom Severity in Anorexia Nervosa. Karen K. Miller, Tamara L. Wexler, Alicia M. Zha, Elizabeth A. Lawson, Erinne M. Meenaghan, Madhusmita Misra, Anna B. Binstock, David B. Herzog, and Anne Klibanski
[Abstract] [PDF]

ASCP Corner

966 Pharmacoepidemiology: Recent Findings and Challenges for Child and Adolescent Psychopharmacology. Julie Magno Zito
[PDF]

A Psychiatrist's Diary

968 The Paranoia of Prejudice. Shyam K. Bhat
[PDF]

Letters To the Editor

970 Schizophrenia Symptoms Remain Stable During Decreases From 2 Antipsychotics to Aripiprazole. Carl Salzman, Jennifer Rosenberg, and James J. Feldman
[PDF]

970 Modafinil: Mischaracterization. Stefan P. Kruszewski and Steven G. Klotz
[PDF]

  • Reply by Joseph Biederman

972 Aripiprazole Augmentation of Clomipramine-Refractory Obsessive-Compulsive Disorder. Serge Friedman, Tania Abou Abdallah, Mohamed Oumaya, Frédéric Rouillon, and Julien-Daniel Guelfi
[PDF]

973 Lack of Mania Prophylaxis Associated With Lamotrigine Monotherapy in Manic-Predominant Bipolar I Disorder. Emily C. Dossett, Alisa J. Land, Michael J. Gitlin, and Mark A. Frye
[PDF]

974 A Different Mechanism to Understand Activation/Sedation Side Effects of Ziprasidone. Michael Haas Brophy
[PDF]

  • Reply by Stephen M. Stahl

976 Attention-Deficit/Hyperactivity Disorder, Binge Eating, and Obesity. Samuele Cortese, Pascale Isnard, Bernardo Dalla Bernardina, and Marie-Christine Mouren
[PDF]

  • Reply by Craig B. H. Surman, Edin T. Randall, and Joseph Biederman

Book Reviews 978

Electronic CME Activities

Available through www.psychiatrist.com/toc

e14 Monitoring and Managing Weight Gain in the Mentally Ill. Rohan Ganguli, Betty Vreeland, and John W. Newcomer

e15 Managing ADHD in the Presence of Comorbid Substance Use Disorder. Himanshu P. Upadhyaya

e16 Implementing Evidence-Based Medicine: Lessons From Public Mental Health Settings. Joseph J. Parks and John W. Newcomer